Active-ingredient Dossier

"formoterol Fumarate Dihydrate"]

Active-ingredient Dossier for "formoterol Fumarate Dihydrate"] (long-acting beta agonist). Australian brands, products, PBS listings, PBAC outcomes —…

Brand: BUDEFLO
Therapeutic area: Respiratory

What is

Formoterol Fumarate Dihydrate Formoterol Fumarate Dihydrate is a long-acting beta agonist.

Australian brands containing

Formoterol Fumarate Dihydrate — OXIS TURBUHALER — BUFOMIX EASYHALER — SYMBICORT — FLUTIFORM — RILAST — BECLOFORM — BEVESPI — BUDEFLO — FORACORT

Therapeutic areas

Formoterol Fumarate Dihydrate is registered in the respiratory therapeutic area, with 9 brands containing the ingredient.

Sponsor landscape

The ingredient is marketed by four sponsors: AstraZeneca, Cipla, Orion Pharma (AUS), and Mundipharma.

PBS and regulatory activity

One brand containing Formoterol Fumarate Dihydrate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 November 2023, with three brands having PBAC outcomes on record. The latest AusPAR is from 4 February 2013, with two brands having AusPARs on record.